Pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015, TTK Healthcare has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, October 17, 2025, to consider and approve the Unaudited Financial Results of the Company for the Second Quarter ending September 30, 2025. In this connection, pursuant to the Company’s Code of Conduct framed in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 (‘the Code’), Trading Window for dealing in shares of the Company, for persons specified under the Code, shall remain closed from October 01, 2025 to October 19, 2025. Accordingly, all the Designated Persons of the Company and their immediate relatives have been intimated not to trade in the Company’s shares during the aforesaid period of closure of Trading Window.
The above information is a part of company’s filings submitted to BSE.
